Skip to main content
FBIO logo

FBIO · Fortress Biotech, Inc. · Analyst Estimates

Track FBIO — free
$1.93 +0.06 (+3.21%) At close · Oct 27 Q3 2025 earnings call transcript
Market Cap
$68.78M
Shares
36.78M
Volume · Oct 27 157.14K Avg daily vol (3M) 418.62K

Analyst Estimates

Compare analyst forecasts for Fortress Biotech, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 08:29 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
2.55
2.55
2.55
1
2.40
2.40
2.40
2.40
0
0
1
1
Revenue
USD
Publication date not stated
78.79M
78.79M
78.79M
1
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.00
-1.00
-1.00
1
-0.50
-0.50
0.51
0.51
1
1
0
0
Revenue
USD
Publication date not stated
113.25M
113.25M
113.25M
1
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.27
-0.27
-0.27
1
-0.15
-0.15
-0.15
-0.15
1
1
0
0
Revenue
USD
Publication date not stated
21.58M
21.58M
21.58M
1
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.25
-0.25
-0.25
1
-0.14
-0.14
-0.14
-0.14
1
1
0
0
Revenue
USD
Publication date not stated
22.46M
22.46M
22.46M
1
— — — — — — — —
Key facts CIK 1429260 CUSIP 34960Q307 13F (30d) 3 filings 3 filers Visit website Investor relations